| Similar Articles |
|---|
 |
Chemistry World
May 19, 2008
Hepeng Jia |
China's one stop research shop John Oyler has founded a string of startups in the US, but in 2005 he chose China as his base to launch BioDuro, a life sciences Contract Research Organisation.   |
Pharmaceutical Executive
September 1, 2008
Zhu Shen |
Unleash the Dragon Concerns over quality? It's not stopping Big Pharma outsourcing and venture capital. |
BusinessWeek
November 19, 2009
Pete Engardio |
China's Reverse Brian Drain Beijing is making progress in its effort to lure back top Chinese scientists working overseas. |
BusinessWeek
December 13, 2004
Bruce Einhorn |
Go East, Big Pharma Drugmakers are expanding in China, but patents are still a worry. |
Pharmaceutical Executive
December 1, 2010
Zhu Shen |
China 2020: Walled In No More Pharma sets the pace for China's ambitious new innovation agenda |
The Motley Fool
August 13, 2007
Andrew R. Vaino |
Do You See What I WuXi? This Chinese biotech outsourcing firm recently went public and has lots of room to grow. |
Bio-IT World
November 14, 2003
John Russell |
China's Early Bet on Bio-IT A visit to Shanghai, China's future capital of biotech |
Chemistry World
December 2006
Derek Lowe |
Opinion: In the Pipeline A look at the story behind the growing investment by western companies in medicinal chemistry research in China. |
Pharmaceutical Executive
September 1, 2008
Patrick Clinton |
Attack of the Junk The United States makes the best medicines in the world. In days to come, that could be a problem. |
BusinessWeek
November 6, 2006
Bruce Einhorn |
A Dragon In R&D China's labs may soon rival its powerhouse factories - and multinationals are flocking in for tech innovation. |
Bio-IT World
October 14, 2004
Robinson & Violino |
Strategic Insights: Global Positioning International Economic Development for biotech companies in search of a better location or international presence, countries in Asia and Europe are offering a host of incentives, including tax credits and reduced red tape. |
The Motley Fool
November 12, 2009
Brian Orelli |
How Do You Say 'Drug Development' in Mandarin? Drug giant Novartis announces that it's heading to China in a big way. |
The Motley Fool
January 31, 2011
Brian Orelli |
Pharma Goes Back to School But will it produce more drugs? The pharmaceutical industry is headed back to school, with a number of large drugmakers announcing partnerships with universities. |
Bio-IT World
December 10, 2002
Malorye Branca |
The Trouble with Pharmaceutical Innovation There's a lot of one kind, but not enough of another in pharma land. Too many new technologies and too few new drugs -- that sums up the state of pharmaceutical R&D. |
Chemistry World
August 21, 2013
Phillip Broadwith |
Two way traffic for Chinese drug licensing Chinese companies have trailed behind their Western counterparts in developing innovative new drugs. Very few of those inventions have been considered useful enough to be licensed by western companies. However, that appears to be changing. |
Bio-IT World
October 14, 2004
Michael Greeley |
Go East Business is great in China, and the government is strongly encouraging the local biotech industry. |
Bio-IT World
June 15, 2003
Barbara Depompa |
Southwest Region Texas: Bioscience with a Space Spin... New Mexico: Building a Bioinformatics Niche... Arizona: Focus on Cancer and Neurological Therapy... Southern California: Deep Biotech Roots Grow Many Branches... Northern California: 'Can You Afford To Be Elsewhere?'... |
The Motley Fool
December 27, 2007
Brian Orelli |
Drugmaker Growth: The China Connection Just like other industries, the pharmaceutical industry has realized that China is a good place to find cheap labor. While reluctant to set up FDA-regulated manufacturing plants in China, other stages of drug development can be done there. |
Pharmaceutical Executive
December 1, 2011
George Baeder |
China's Future in Bioscience Will big investments in infrastructure carry the day in positioning China as a global drug innovation powerhouse? |
Pharmaceutical Executive
September 1, 2012
Roy F. Waldron |
Open Innovation in Pharma: Defining the Dialogue There is much talk today about "open innovation" in business and research forums, but what exactly does it mean? How does open innovation as a concept apply to the pharmaceutical sector? |
Chemistry World
October 28, 2014
Hepeng Jia |
China's science academy launches new reform drive The Chinese Academy of Sciences, the nation's largest research body, is to reshuffle its 100 plus research institutes and change the way it rewards scientists. |
Pharmaceutical Executive
March 1, 2013 |
Country Report: China China's pharmaceutical industry is making record gains. Four years ago, China was the world's fifth largest market. Now, it has bypassed France and Germany to become the third largest. |
BusinessWeek
November 6, 2006
Bruce Einhorn |
A Growing Cadre Of Code Warriors China's young programming hotshots are gaining global attention. |
Bio-IT World
June 15, 2003
Melissa Kruse |
Midwest/South Region Ohio: Outpacing U.S. in Bioscience Growth... Alabama: Sweet Home to Tech Tax Incentives... Kentucky: Investing Multimillions to Breed Bio Business... Minnesota: The 'Right Mix' of Talent and Funding... Tennessee: Pioneering Research Centers... Michigan: Teeming 'Life Sciences Corridor'... etc. |
HBS Working Knowledge
January 22, 2007
Michael Roberts |
The Immigrant Technologist: Studying Technology Transfer with China Professor William Kerr discusses the phenomena of technology transfer and implications for U.S.-based businesses and policymakers. |
Bio-IT World
June 15, 2003
Bob Violino |
Mid-Atlantic/Southeast Region Maryland: Making a Federal Case for Biotechnology... Puerto Rico: Isle of Incentives... Virginia: Planting Needed Seed Capital... North Carolina: Triangulating Biotech Resources... Florida: Shining Resources on Small Biotech Sector |
Fast Company
June 2006
Robert Buderi |
The Talent Magnet Kai-Fu Lee, technologist and self-help guru, is a raging celebrity on Chinese university campuses. Now Google is paying him upward of $10 million to build its research lab in Beijing - and to tap into the future. |
Chemistry World
November 20, 2007
Hepeng Jia |
China Leaps up Research League Table China has overtaken Japan and the UK to become the world's second largest producer of science and technology (S&T) papers. |
Chemistry World
January 2008
Victoria Gill |
A Model City Shanghai is being sculpted into the ideal of a modern Chinese city. It's also becoming China's center for scientific innovation. |
IEEE Spectrum
June 2005 |
Ten to Watch Here are some of China's leading technologists: Richard Chang, CEO of Semiconductor Manufacturing International Corp... Gao Wen, head of China-led international group developing a royalty-free standard called AVS... etc. |
BusinessWeek
April 2, 2007
Bruce Einhorn |
Grudge Match In China HP and Dell are exporting their rivalry and starting to challenge Lenovo. |
HBS Working Knowledge
November 5, 2007
Sarah Jane Gilbert |
The Changing Face of American Innovation Chinese and Indian scientists and engineers have made a large contribution to U.S. technology over the last 30 years, according to research by Harvard professor William R. Kerr. But that trend may be ebbing, with potentially harmful effects on American innovation. |
BusinessWeek
September 26, 2005
Frederik Balfour |
Stealing Managers From The Big Boys Chinese companies are energetically wooing executives away from multinationals. |
BusinessWeek
August 4, 2003
Bruce Einhorn |
Outsourcing: Make Way for China It's fast becoming an important hub for IT services. Move over, India. |
The Motley Fool
March 8, 2007
Dave Mock |
Your Guide to International Stocks China's future is not only about cheap labor, but a new wave of Chinese technical talent coming into the local economy. But how investors profit from this trend is not necessarily straightforward. |
Chemistry World
November 10, 2015
Hepeng Jia |
China's first science Nobel prize exposes anxiety on research Artemisinin saves tens of thousands of lives every year. The story of its discovery has been debated for decades in China. The awarding of the medicine Nobel prize has only served to reopen old wounds. |
The Motley Fool
March 6, 2009
Brian Orelli |
For Drug Companies, R&D Is Spelled C-R-O It seems likely that more and more pharma companies will try to get more bang for their bucks by spending them on research and development done outside the company, outsourcing it to clinical research organizations. |
The Motley Fool
March 26, 2009
Brian Orelli |
Big Pharma's R&D Model Is Broken Bigger isn't always better. |
Chemistry World
October 11, 2007
Hepeng Jia |
China's Drug Industry Set to Take Off Producing cheap drugs for the developing world could allow Chinese pharmaceutical firms to capture a bigger share of the international market, industry experts suggest. |
Pharmaceutical Executive
December 1, 2008
Walter Armstrong |
The New Deals Everything you wanted to know about the year's most important deals, and what to watch for in the future. |
BusinessWeek
November 21, 2005
David Rocks |
China Design How China is becoming a global center for hot products. |
BusinessWeek
May 29, 2006
Bruce Einhorn |
Science Friction Is the controversy over research fraud in China spiraling out of control? |
The Motley Fool
May 18, 2010
Brian Orelli |
What Astellas' Purchase of OSI Means for Biotech Investors Stop buying for the potential takeout. |
BusinessWeek
June 13, 2005
Catherine Arnst |
Biotech, Finally The past 30 years of biological discoveries, insights into the human genome, and exotic chemical manipulation have unleashed a wave of biological drugs, many of them reengineered human proteins. |
BusinessWeek
July 23, 2007
Engardio et al. |
Broken China Beijing can't clean up the environment, rein in stock speculation, or police its companies. Why the mainland's problems could keep it from becoming the next superpower |
Bio-IT World
June 15, 2003
Bob Violino |
Northeast Region Massachusetts: University and Research Hub... Connecticut: Investing in Bio Facilities... New York: Biotech Empire State... New Jersey: Still Big Pharma Country... Pennsylvania: Life Sciences, a Keystone Industry |
The Motley Fool
November 30, 2010
Brian Orelli |
A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist. |
Pharmaceutical Executive
October 1, 2006
Ray Hill |
China: Big Rewards. Bigger Risks? The world's fastest growing pharmaceutical market may one day be the largest. Breaking in could be industry's greatest challenge. |
Chemistry World
July 15, 2008
Hepeng Jia |
Testing Times for New Liver Drug AstraZeneca is set to start clinical trials of a liver cancer drug developed for Chinese patients. |
Bio-IT World
March 10, 2003
Mark D. Uehling |
Technology Overload Inundated with new IT tools and mountains of data, the pharmaceutical industry struggles to pull it all together. |
